N. E. Kocer And F. KAYASELÇUK, "Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?," TARGETED ONCOLOGY , vol.9, no.2, pp.171-175, 2014
Kocer, N. E. And KAYASELÇUK, F. 2014. Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?. TARGETED ONCOLOGY , vol.9, no.2 , 171-175.
Kocer, N. E., & KAYASELÇUK, F., (2014). Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?. TARGETED ONCOLOGY , vol.9, no.2, 171-175.
Kocer, Nazim, And FAZİLET KAYASELÇUK. "Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?," TARGETED ONCOLOGY , vol.9, no.2, 171-175, 2014
Kocer, Nazim E. And KAYASELÇUK, FAZİLET. "Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?." TARGETED ONCOLOGY , vol.9, no.2, pp.171-175, 2014
Kocer, N. E. And KAYASELÇUK, F. (2014) . "Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?." TARGETED ONCOLOGY , vol.9, no.2, pp.171-175.
@article{article, author={Nazim Emrah Kocer And author={FAZİLET KAYASELÇUK}, title={Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?}, journal={TARGETED ONCOLOGY}, year=2014, pages={171-175} }